Loading market data...
Latest Top News
Despite Q4 Miss, Gland Pharma’s ₹18 Dividend Keeps Investors Smiling
Gland Pharma has announced a substantial ₹18 per share dividend for FY25, even as its March quarter results came in below analyst expectations, reflecting both resilience and challenges in the current operating environment.
Key Highlights:
Dividend Boost: The board has reco...
Stay Ahead – Explore Now! Anthropic Disables Advanced AI Models Sparks Indian Sovereignty Debate






